A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

This specialty biopharmaceutical company focuses on oncology and critical care medications, offering a diverse portfolio of over 650 product registrations across regions including the EU, North America, and Asia. Their expertise includes developing innovative, cost-effective drug delivery systems like microspheres, liposomes, and nanoparticles. They are recognized for manufacturing high-quality products adhering to global standards such as WHO-GMP and Schedule M certifications. Key therapy areas include oncology (with a focus on oral medications) and critical care, encompassing cardiovascular and anesthesia segments. The company has launched several first-in-market products and continues to expand its presence globally.

This family-owned specialty pharmaceutical company focuses on providing high-quality oncology drugs to over 20 countries worldwide. With more than two decades of experience, they specialize in manufacturing sterile oncology dosage forms, including liquid vials, lyophilized formulations, and complex NDDS-based products. Their product portfolio includes over 35 products targeting various solid tumors and hematological malignancies, with a commitment to palliative care formulations as well. They prioritize research and development, particularly in advanced lyophilized, liposomal, and nanoparticle-based drug delivery systems. Their manufacturing facilities adhere to strict GMP certifications, ensuring product quality and safety. Key therapy areas include oncology, with a focus on solid tumors and hematological malignancies. Principal dosage forms include liquid vials, lyophilized formulations, and complex NDDS (New Drug Delivery Systems) based products. The company emphasizes partnerships with academia, healthcare institutions, and the local community to drive research and development efforts.